Clinical Indication ID & Name
Breast Cancer
Test Group
Solid Tumours (Adult)
Specialties
Test code
M3.2
Test name
Multi-target expression array (Oncotype DX)
Target genes
Multiple - as per proprietary NICE-approved assay
Test scope
Other - Gene Expression
Test method/ technology
Other
Optimal Family Structure
n/a
Eligibility Criteria
As per NICE recommendations in ER positive, HER2 negative, lymph node negative early breast cancer
Test code
M3.3
Test name
Multi-target expression array (Endopredict)
Target genes
Multiple - as per proprietary NICE-approved assay
Test scope
Other - Gene Expression
Test method/ technology
Other
Optimal Family Structure
n/a
Eligibility Criteria
As per NICE recommendations in ER positive, HER2 negative, lymph node negative early breast cancer
Test code
M3.4
Test name
Multi-target expression array (Prosignia)
Target genes
Multiple - as per proprietary NICE-approved assay
Test scope
Other - Gene Expression
Test method/ technology
Other
Optimal Family Structure
n/a
Eligibility Criteria
As per NICE recommendations in ER positive, HER2 negative, lymph node negative early breast cancer
Test code
M3.5
Test name
Multi-target NGS panel - structural variant (NTRK1, NTRK2, NTRK3)
Target genes
NTRK1, NTRK2, NTRK3
Test scope
Structural variant detection
Test method/ technology
Panel
Optimal Family Structure
n/a
Eligibility Criteria
Patient’s clinical status means they are eligible for an NTRK inhibitor in the event an NTRK rearrangement is detected
Test code
M3.6
Test name
Multi-target NGS panel - small variant (PIK3CA)
Target genes
PIK3CA
Test scope
Small variant detection
Test method/ technology
Panel
Optimal Family Structure
n/a
Eligibility Criteria
Molecular assessment will aid diagnosis or management
Test code
M3.7
Test name
DPYD hotspot
Target genes
DPYD
Test scope
Small variant detection
Test method/ technology
Simple targeted mutation testing
Optimal Family Structure
n/a
Eligibility Criteria
Patient planned to receive fluoropyrimidine treatment
Test code
M3.9
Test name
ETV6-NTRK3 FISH/RT-PCR
Target genes
ETV6-NTRK3
Test scope
Structural variant detection
Test method/ technology
FISH/Simple targeted mutation testing
Optimal Family Structure
n/a
Eligibility Criteria
To support testing for suspected secretory carcinoma of the breast. Specialist pathology review indicates that molecular assessment will aid diagnosis or management.
Commissioning group
n/a
Overlapping idications
n/a
Address for samples/request forms
North Thames GLH, Rare & Inherited Disease Genomic Laboratory
Specimen Reception, Level 5 Barclay House, 37 Queen Square,
London WC1N 3BH
Contact with queries
Supporting documents
Cancer WGS Clinician pack
Education resources
n/a
Service updates
n/a
Request form download
Consent record
See consent guidance in test request form
Sample requirements
See sample guidance in test request form